1 Market Overview
1.1 Human Normal Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Normal Immunoglobulin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Normal Immunoglobulin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Overview of Global Human Normal Immunoglobulin Market
1.4.1 Global Human Normal Immunoglobulin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Human Normal Immunoglobulin Industry Impact
1.6.1 COVID-19 Potential Implications for the Human Normal Immunoglobulin
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Human Normal Immunoglobulin
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CSL Behring SWOT Analysis
2.1.4 CSL Behring Product and Services
2.1.5 CSL Behring Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 CNBG
2.2.1 CNBG Details
2.2.2 CNBG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 CNBG SWOT Analysis
2.2.4 CNBG Product and Services
2.2.5 CNBG Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Kedrion
2.3.1 Kedrion Details
2.3.2 Kedrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Kedrion SWOT Analysis
2.3.4 Kedrion Product and Services
2.3.5 Kedrion Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Grifols SWOT Analysis
2.4.4 Grifols Product and Services
2.4.5 Grifols Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kamada
2.5.1 Kamada Details
2.5.2 Kamada Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Kamada SWOT Analysis
2.5.4 Kamada Product and Services
2.5.5 Kamada Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biotest
2.6.1 Biotest Details
2.6.2 Biotest Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biotest SWOT Analysis
2.6.4 Biotest Product and Services
2.6.5 Biotest Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Shanghai RAAS SWOT Analysis
2.7.4 Shanghai RAAS Product and Services
2.7.5 Shanghai RAAS Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Emergent (Cangene)
2.8.1 Emergent (Cangene) Details
2.8.2 Emergent (Cangene) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Emergent (Cangene) SWOT Analysis
2.8.4 Emergent (Cangene) Product and Services
2.8.5 Emergent (Cangene) Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 CBPO
2.9.1 CBPO Details
2.9.2 CBPO Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 CBPO SWOT Analysis
2.9.4 CBPO Product and Services
2.9.5 CBPO Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hualan Bio
2.10.1 Hualan Bio Details
2.10.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Hualan Bio SWOT Analysis
2.10.4 Hualan Bio Product and Services
2.10.5 Hualan Bio Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sichuan Yuanda Shuyang
2.11.1 Sichuan Yuanda Shuyang Details
2.11.2 Sichuan Yuanda Shuyang Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sichuan Yuanda Shuyang SWOT Analysis
2.11.4 Sichuan Yuanda Shuyang Product and Services
2.11.5 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 ADMA Biologics
2.12.1 ADMA Biologics Details
2.12.2 ADMA Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 ADMA Biologics SWOT Analysis
2.12.4 ADMA Biologics Product and Services
2.12.5 ADMA Biologics Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Normal Immunoglobulin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Normal Immunoglobulin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Normal Immunoglobulin Manufacturer Market Share in 2019
3.3.2 Top 6 Human Normal Immunoglobulin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Normal Immunoglobulin Sales, Revenue and Market Share by Regions
4.1.1 Global Human Normal Immunoglobulin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Normal Immunoglobulin Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.3 Europe Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.5 South America Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
5.1.1 North America Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
5.2 United States Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
5.3 Canada Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
5.4 Mexico Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
6.1.1 Europe Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.3 UK Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.4 France Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.5 Russia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.6 Italy Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Normal Immunoglobulin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Normal Immunoglobulin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Normal Immunoglobulin Revenue and Market Share by Regions (2015-2020)
7.2 China Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.3 Japan Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.4 Korea Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.5 India Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.7 Australia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
8.1.1 South America Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
8.3 Argentina Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9.3 Turkey Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9.4 Egypt Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9.5 South Africa Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Normal Immunoglobulin Sales and Market Share by Type (2015-2020)
10.2 Global Human Normal Immunoglobulin Revenue and Market Share by Type (2015-2020)
10.3 Global Human Normal Immunoglobulin Price by Type (2015-2020)
11 Global Human Normal Immunoglobulin Market Segment by Application
11.1 Global Human Normal Immunoglobulin Sales Market Share by Application (2015-2020)
11.2 Global Human Normal Immunoglobulin Revenue Market Share by Application (2015-2020)
11.3 Global Human Normal Immunoglobulin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Normal Immunoglobulin Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Normal Immunoglobulin Market Forecast by Regions (2021-2025)
12.2.1 North America Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.2 Europe Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.4 South America Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Normal Immunoglobulin Market Forecast (2021-2025)
12.3 Human Normal Immunoglobulin Market Forecast by Type (2021-2025)
12.3.1 Global Human Normal Immunoglobulin Sales Forecast by Type (2021-2025)
12.3.2 Global Human Normal Immunoglobulin Market Share Forecast by Type (2021-2025)
12.4 Human Normal Immunoglobulin Market Forecast by Application (2021-2025)
12.4.1 Global Human Normal Immunoglobulin Sales Forecast by Application (2021-2025)
12.4.2 Global Human Normal Immunoglobulin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【掲載企業】
CSL Behring、CNBG、Kedrion、Grifols、Kamada、Biotest、Shanghai RAAS、Emergent (Cangene)、CBPO、Hualan Bio、Sichuan Yuanda Shuyang、ADMA Biologics
【免責事項】
https://www.globalresearch.jp/disclaimer